Feed ARCL.BO
Summary
54 / 100 · Bulios Score
Valuation 45Growth 60Profitability 34Quality 45Debt 68Stability 83
What speaks for it
- Revenue grew by 18% a year over the last 3 years.
- It could repay all its net debt from 2.0 years of operating profit.
What to watch
- Earnings per share fell by 24% a year over the last 3 years.
- You pay 36.8 INR for 1 INR of yearly profit, a lot for its sector.
- It reports a profit, yet spends more cash than it brings in.
- It earns only 3.4 INR a year on every 100 INR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedP/E against the industry (Chemicals - Specialty)
P/E today 36.8 Industry median 26.1
Today you pay 36.8 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (INR)
20212022202320242025
Diluted EPS (INR)
20212022202320242025
Revenue grew by 18% a year over the last 3 years. Earnings per share fell by 24% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 71 INR
- Sales and administration 19 INR
- Taxes and other 6.2 INR
- Net profit 3.8 INR
Net profit, industry median (Chemicals - Specialty) 2.0 INR
Out of every 100 INR of revenue, 3.8 INR is left as net profit.
Profitability in detailIs it financially healthy?
Cash and short-term investments ₹226.4M
Debt ₹709.3M
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail